Since the publication of the above article, the authors have identified errors in the results and figures.
Please find below the detailed description of the new results and figures in their entirety.
In that work the expression of PTPN22 alleles in individuals heterozygous for the C1858T SNP was measured using a fluorescent PCR-RFLP analysis. By mistake one of the primers used for both the PCR-RFLP and RT-PCR analysis is situated in an intron. Because the non-RT controls excluded contamination with genomic DNA, it is most likely that the published relative expression of PTPN22 alleles was at the pre-mRNA level and not the mRNA level as stated in the paper. All samples have now been reanalyzed with the mRNAspecific primers listed below, and essentially identical results are obtained. The conclusions drawn in the manuscript are therefore valid for both pre-mRNA and mRNA.
RFLP analysis: This was performed using a forward primer: 5 0 -CTGTACTAGCAACTGCTCCA-3 
Detailed description of the new results and figures
For the fluorescent capillary electrophoresis, the PCR was performed using a forward primer (5 0 -CTGTAC TAGCAACTGCTCCA-3 0 (corresponding to positions 1891-1910 of the PTPN22 mRNA, GenBank accession no. NM-015967) and a reverse primer: 5 0 -GGTCTAAGTAT-CACAGAGTC-3 0 (corresponding to positions 2088-2107 of the PTPN22 mRNA, GenBank accession no. NM-015967)) labeled at its 5 0 end with the fluorescent dye FAM and designed to amplify a 217 bp FAM-labeled mRNA-specific fragment of PTPN22 containing the C1858T SNP. Relative allelic expression analysis For each cDNA sample from heterozygous individuals, the relative expression of the PTPN22 1858T and 1858C allele was calculated as the ratio of the peak areas of the 217 bp fragment and the 162 bp fragment.
Regulation of PTPN22 mRNA and relative allelic expression in stimulated PBMCs over time The reaction was carried out with the SYBR Green PCR Master Mix, 3 ml of cDNA and 5 pmol of each mRNAspecific primer (forward primer: 5 0 -CTGTACTAG CAACTGCTCCA-3 0 (corresponding to positions 1891-1910 of the PTPN22 mRNA, GenBank accession no. NM-015967); reverse primer: 5 0 -TCCAGCTTCCTCAACCA CAA-3 0 (corresponding to positions 1966-1985 of the PTPN22 mRNA, GenBank accession no. NM-015967)) designed to amplify a 95 bp mRNA-specific fragment of PTPN22.
The mRNA induction index of PTPN22 in PBMCs increased approximately twofold following 6 h of stimulation (P ¼ 0.012; one-way repeated measures ANOVA; Bonferroni-adjusted P-value) and remained relatively unchanged until 48 h of anti-CD3 and anti-CD28 stimulation, where the mRNA expression of PTPN22 was upregulated approximately eight times compared to non-stimulated cells (Po0.0001). Following 72 h of stimulation, the mRNA expression of PTPN22 was further upregulated compared to 48 h of stimulation (Po0.0001) and reached an approximately 24 times higher level compared to nonstimulated PBMCs (Po0.0001). The level of DNA contamination was low as no-reverse transcription controls always resulted in CT values higher than the 40 cycles detected in the RT-PCR (Figures 1-3 ).
Conclusion
As published in the article, the expression of PTPN22 1858C and T alleles in anti-CD3-and anti-CD28-stimulated PBMCs was increased to the same extent and followed the same kinetics using the new mRNAspecific primers -just at a higher level. The use of the new mRNA-specific primers supported the published absence of any significant sex-specific variability in relative mRNA allele ratio.
The authors would like to apologize for these errors. Allele-specific expression assayed at the PTPN22 1858C/T SNP in the same anti-CD3 and anti-CD28 over time. Data are expressed (n ¼ 10) as the ratio of T:C alleles. The data are the peak area averages of two measurements for each individual sample. There was no significant difference in the allele ratio between the different stimulation times.
